Maternal screening for neural tube defects and fetal genetic disorders is a crucial part of maternal care. Results from several recent multicentric studies have shifted the focus of such tests from the second trimester to the first. This shift in earlier testing is associated with several advantages, including earlier diagnosis, better prenatal care, etc. Timely prenatal testing, along with the use of non-invasive testing methods, and the latest cytogenetic methods can be extremely useful in ensuring optimal maternal health. But how can one leverage these tools to ensure good maternal outcomes?
Find out in this enlightening session presented in association with Metropolis, where Dr. Mohit Shah and Dr. Talat Khan share their expert insights on the importance of effective screening methods in the first trimester. Join us on 8 th March 2024 , 6:30 PM onwards. Session highlights First…
